Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01, R21)

Funding Agency:
National Institutes of Health

 This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system.  Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

RFA-MH-18-300 uses the R01 grant mechanism while RFA-MH-18-301 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data may wish to apply using the R01 mechanism.


  • Letter of Intent Due Date(s): August 7, 2017
  • Application Due Date(s): September 6, 2017
  • AIDS Application Due Date(s): September 6, 2017

​RFA-MH-18-300 Expiration Date September 7, 2017




Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 6, 2017